Breakthrough financing solution guarantees 100% patient approval, instant 90-second decisions, and interest-free payments while providing fast funding to healthcare practices. With an easy digital process that eliminates delays, this innovative offering empowers healthcare providers such as med spas, dentists, chiropractors and health coaches to eliminate financial barriers to patient care while boosting revenue.
PORT ST. LUCIE, Fla., March 18, 2025 /PRNewswire/ — Flexxbuy, a leading provider of patient financing solutions, today announced the broad release of its breakthrough patient financing platform designed for healthcare and wellness providers. This innovative 0% APR financing solution has 100% approval for every patient in under 90 seconds, eliminating financial barriers to treatment and enabling providers – from medical spas and chiropractic clinics to dental practices and health coaching services. With Flexxbuy’s new program, every patient gets approved for an interest-free payment plan, ensuring cost is no longer an obstacle while healthcare practices enjoy prompt, reliable funding
Key benefits of Flexxbuy’s patient financing solution include:
“Cost should never prevent a patient from getting the care they need or want, and providers shouldn’t have to turn anyone away,” said Bob Lovinger, President and Founder of Flexxbuy. “This 0% APR, everyone-approved breakthrough financing program is a game-changer for healthcare practices and patients. It cohesively fits into any office workflow by delivering reliable outcomes. Providers can focus on delivering great care knowing they’ll be paid quickly, while patients can move forward with treatment on an affordable, interest-free plan. Everyone wins.”
The platform is easily accessed through a secure online portal, making it simple to access straightforward financing options. The result is a cohesive “breakthrough” experience for providers and patients: applications are quick and paperless, and approvals are instant.
By removing the two most significant pain points in patient financing – high interest rates and credit denials – Flexxbuy empowers healthcare businesses to serve more patients and increase their revenue. Patients who might have postponed or declined treatment due to cost can now proceed with necessary or desired services, improving health outcomes and patient satisfaction.
Early adopters in healthcare have already reported a significant increase in patients moving forward with recommended treatments once financing became transparent and affordable. With Flexxbuy, there are no barriers, no confusion – just a straightforward way to finance patient care.
For more information about Flexxbuy’s 0% APR “everyone-approved” patient financing solution, healthcare providers are encouraged to visit Flexxbuy.com/patient-fin or contact Brett Walisever at 702-324-1221 or 391998@email4pr.com.
About Flexxbuy
Flexxbuy is a U.S. industry leader in consumer financing innovation, providing businesses with finance options through its online multi-lender platform and specialty financing programs. Since its inception in 2014, Flexxbuy has helped thousands of merchants across numerous industries offer flexible payment solutions. The company’s diverse financing products, including its new, everyone-approved, zero-interest patient financing program, reflect a commitment to “no one-size-fits-all” solutions. By leveraging a broad network of lenders and cutting-edge technology, Flexxbuy delivers high approval rates, fast funding and exceptional support. Flexxbuy continues to drive innovation in the patient financing space, empowering businesses and professionals to enjoy higher revenue while helping more patients.
SOURCE Flexxbuy LLC
Data to be presented in Clinical Trials in Progress Session on Monday, April 28, 2025CORAL…
More than 50% of men now face erectile dysfunction after the age of 40. In…
BEIJING, April 27, 2025 (GLOBE NEWSWIRE) -- On April 25, 2025, the 66th (Spring 2025)…
After six months of research on the ingredients and thousands of feedback from real consumers,…
Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT InterventionsSOUTH SAN FRANCISCO, Calif.,…
- Robust 24-month complete response rate of 42.3% by K-M for cretostimogene monotherapy in BOND-003…